Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miglustat Maintenance in Type 1 Gaucher Disease
NCT00319046Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Feb 2006
- Primary completion
- Jun 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of miglustat in Gaucher disease type 1 (GD1), sponsored by Actelion Pharmaceuticals Ltd. Started Feb 2006; status: completed.
02
Drugs
miglustat
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NCT00319046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319046.